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Introduction: For interpretation of body plethysmographic static hyperinflation, reference 
values are of crucial importance. Earliest reference values have been published by the European 
Coal and Steel Community (ECSC) and are based on sex, body height and age as predictors. 
As obesity can lead to a reduction of functional residual capacity (FRC) in lung-healthy subjects, 
more recent approaches included body weight or body surface area. This raises the question 
whether these models are appropriate in patients with COPD-induced hyperinflation.
Method: Several FRC prediction models and their relation to body weight were analyzed in 1513 
patients with stable COPD (mean [SD] age: 64.5 [8.2] years; GOLD grades 1–4: 219/722/484/88), a 
subset of the multicenter COPD and Systemic Consequences – Comorbidities Network cohort.
Results: Absolute values of FRC were inversely related to body mass index (p,0.001). Apply-
ing the ECSC equations to calculate predicted values, this pattern was maintained (p,0.001). 
By contrast, an inverted, ie, positive, relation occurred when using equations that include body 
weight or surface area (p,0.001). The present analysis confirmed the inverse relation of body 
mass and FRC in COPD, resulting from a restrictive ventilatory pattern by diaphragm elevation 
and decreased chest wall compliance in obesity. The weight influence in the prediction models, 
as obtained from lung-healthy controls, appears to lead to an overcorrection and consequently to 
an inappropriate overestimation of hyperinflation as indicated by FRC %predicted in COPD.
Conclusion: It is concluded that models not including body weight as predictor, like the clas-
sical ECSC equations, could be superior in the interpretation of FRC in COPD.
Keywords: static hyperinflation, body plethysmography, functional residual capacity, COPD, 
body mass
Introduction
Reference values are crucial for the interpretation of lung function impairments in 
patients with airway disorders including COPD. While body plethysmography is not 
widely used in academic research, it appears to be established in clinical practice in 
various countries,1 as judged from the numbers of equipment sold. The first refer-
ence values to be used for body plethysmographic measures were published by the 
European Coal and Steel Community (ECSC) and are based on sex, height and age 
as predictors.2 More recent approaches include body weight or body surface area3–5 
as obesity can lead to a reduction of functional residual capacity (FRC) in lung-
healthy subjects. This raises the question whether these weight-including models 
are appropriate in patients in whom COPD induces lung hyperinflation,6 which may 
counteract effects of obesity on FRC. This would crucially affect the clinical inter-
pretation of FRC measurements.
We therefore analyzed various FRC prediction models and their relation to body 
weight in patients with stable COPD using data from the German COPD cohort 
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COSYCONET (COPD and Systemic Consequences – 
Comorbidities Network).
Methods
In COSYCONET, 2,741 patients with stable COPD were 
enrolled.7 The study was approved by the Ethics Committee 
of the University of Marburg as coordinating center and by 
the ethics committees of all study centers; it is registered on 
ClinicalTrials.gov (registration number NCT01245933). All 
study participants provided written informed consent. For 
the present analysis, data from Visit 1 (recruitment), Visit 2 
(6-month follow-up) and Visit 3 (18-month follow-up) were 
used. Spirometry and body plethysmography was performed 
after inhalation of 400 µg salbutamol and 80 µg ipratropium 
bromide7 following the recommendations by the American 
Thoracic Society (ATS)/European Respiratory Society 
(ERS)8 and Deutsche Gesellschaft für Pneumologie und 
Beatmungsmedizin (DGP).1,9 In 28 out of 31 study centers, 
the same equipment and software were used. All measure-
ments were performed by experienced personnel following 
detailed written SOPs, and the data collected were sub-
jected to careful quality control.
In patients with a ratio of forced expiratory volume in 
1 second (FEV
1
) to forced vital capacity ,0.70, airway 
obstruction was quantified via FEV
1
 %predicted10 according 
to the GOLD criteria.11 Only patients with spirometric GOLD 
grades 1–4 at Visit 1 were included into the present analysis. 
Static lung hyperinflation was measured as body plethysmo-
graphic FRC (intrathoracic gas volume).1
Five different reference equations were used to calculate 
%predicted values of FRC: ECSC as referenced by Quanjer 
et al,2 Cordero et al,3 Koch et al4 and Garcia-Rio et al.5 Except 
for ECSC, all equations include body weight or surface area 
(calculated according to DuBois) as predictor but Garcia-Rio 
et al5 provided an additional equation without weight-related 
predictors (Table 1). Only patients with body mass index 
(BMI) ,40 kg/m² and plausible data on predicted FRC for 
all methods (,300 %predicted) at all visits were included. 
For terms of a sensitivity analysis, patients with BMI $40 
kg/m² were included. Linear regression analysis was applied 
using FRC measured or predicted value as dependent variable 
and BMI as independent variable.
Results
Data from 1,513 patients of GOLD grades 1–4 (n=219/ 
722/484/88) were analyzed. Details of the baseline character-
istics at Visit 1 are shown in Table 2. The mean (SD) duration 
from Visit 1 to Visit 2 was 196 (33) days and from Visit 2 to 
Visit 3 was 377 (55) days. The mean decline of FEV
1
 between 
the visits (1 vs 2 and 2 vs 3) was 0.022 L (95% confidence 
interval [CI] 0.010 to 0.033 L) and 0.070 L (0.058 to 0.082 L), 
respectively. The mean change of FRC was −0.007 L (−0.039 
to 0.025 L) and 0.111 L (0.078 to 0.144 L), respectively. 
Despite the small changes during the follow-up, mean values 
of FRC and BMI from three visits were used in the correlation 
analyses to improve the signal-to-noise ratio. Correction for 
the trend did not lead to any qualitatively different results.
Absolute values of FRC were inversely related to BMI 
(p,0.001; Figure 1). Applying the ECSC equations, the 
pattern was maintained, ie, an increased BMI was related 
Table 1 regression equations for calculation of FrC %predicted
Reference Sex Method
eCsC2 Men 2.34 h + 0.009 a − 1.09
Women 2.24 h + 0.001 a − 1
Cordero et al3 Men 0.089 h − 0.033 W + 0.018 a − 10.185
Women 0.052 h − 0.018 W + 0.004 a − 4.858
Koch et al4 Men −10.419 + 0.0172 a + 0.092 h − 0.0329 W
Women −6.7285 + 0.0631 a − 0.000519 a² + 
0.0603 h − 0.0239 W
garcia-rio et al5 Men −1.425 + 0.02188 a + 0.0000007418 h³ − 
0.00000103 W³
Women 2.276 + 0.0000008882 h³ − 1.96 Bsa
garcia-rio et al5
without weight-
related factors
Men
Women
−1.215 + 0.02434 a + 0.0000005659 h³
0.563 + 0.0000004998 h³
Abbreviations: A, age (yr); BSA, body surface area (m2); ECSC, European Coal 
and Steel Community; FRC, functional residual capacity; H, standing height (m); 
W, weight (kg).
Table 2 Baseline characteristics of the study cohort at Visit 1 
(n=1,513)
Parameter Mean values (SD)
or n (%)
Anthropometry
Age, years 64.5 (8.2)
sex, m/f 928/585
BMI, kg/m² 26.4 (4.7)
Lung function and body plethysmography
gOlD 1/2/3/4 219/722/484/88
FeV1 %predicted 54.97% (18.26%)
FrC, l 4.79 (1.17)
FrC %predicted, eCsC 147.0% (33.3%)
FrC %predicted, Cordero et al3 143.5% (34.6%)
FrC %predicted, Koch et al4 125.4% (28.8%)
FrC %predicted, garcia-rio et al5 152.6% (34.3%)
FrC %predicted, garcia-rio et al5 
without weight-related factors
150.7% (35.0%)
Note: The table shows mean values (±standard deviations), except for sex and 
gOlD grade. FrC %predicted following several methods. 
Abbreviations: BMI, body mass index; ECSC, European Coal and Steel Community; 
FeV1 %predicted, forced expiratory volume in 1 second predicted according to GLI; 
FRC, functional residual capacity.
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to a decreased FRC %predicted ( p,0.001). By contrast, 
FRC %predicted increased with BMI when using equations 
from Cordero et al,3 Koch et al4 and Garcia-Rio et al,5 which 
include body weight or surface area. Using the equations from 
Garcia-Rio et al5 without weight-related terms, a similar pat-
tern as for the ECSC equations was observed (p,0.001 each). 
The slope of the corresponding regression equation (−2.257; 
95% CI: −2.598 to −1.915) did not significantly differ from that 
of ECSC values (−2.356; −2.675 to −2.038), but these slopes 
were clearly different from those of the other approaches 
(Cordero et al: 0.779; 0.428–1.129; Koch et al: 1.001; 
0.722–1.280; Garcia-Rio et al: 1.113; 0.765–1.460). When indi-
viduals with BMI $40 kg/m² were included for the purpose 
of a sensitivity analysis, the observed effects were pronounced.
Figure 1 scatter diagrams and regression lines (p,0.001 each) of static lung volume (FRC) versus BMI in terms of absolute values (A) and %predicted by ECSC2 (B) based 
on body height and age, as %predicted by Cordero et al3 (C), Koch et al4 (D) and garcia-rio et al5 (E) including body weight as predictor; in addition, as %predicted by 
garcia-rio et al5 without weight-related factors (F).
Abbreviations: BMI, body mass index; ECSC, European Coal and Steel Community; FRC, functional residual capacity.
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Discussion
The analysis confirmed that static lung volume in terms of 
body plethysmographic FRC is inversely related to BMI, in 
line with pathophysiologic evidence. An increased adipose 
mass is known to cause elevation of the diaphragm, in addi-
tion to effects exerted by decreased chest wall compliance and 
inducing a restrictive ventilatory pattern.12 This relationship 
also occurred in patients with stable COPD when using the 
absolute values of FRC.
In clinical practice, FRC is evaluated relative to refer-
ence values derived from healthy individuals. Various 
regression equations have been published, which include 
sex, age and height as determinants. The ECSC equations 
are limited to these predictors.2 They yielded an inverse 
relationship between FRC %predicted and BMI, just as 
the absolute values of FRC, thereby matching expectations 
from pathophysiology. The other equations included body 
weight or body surface area as predictors3–5 and resulted in 
an increase of FRC %predicted with increasing BMI, which 
appears implausible. The most likely explanation is that in 
obese patients with COPD the negative weight term in the 
equations, as derived from lung-healthy subjects, leads to an 
overcorrection for weight in the predicted values and con-
sequently to an overestimation of hyperinflation in terms of 
%predicted. Conversely, if correct, it would suggest that lung 
volume in COPD patients with hyperinflation is, on average, 
less affected by obesity than in lung-healthy subjects.
Recognizing the potential problems in obese, lung-
healthy subjects, Garcia-Rio et al already proposed a model 
without weight or weight-related predictors.5 In our COPD 
population, it yielded the same picture as the ECSC 
equations, suggesting that our findings are not due to the 
possibility that the ECSC equations13 are outdated. Moreover, 
the qualitative pattern of correlations was maintained when 
the range of BMI was limited to values ,30 kg/m2, and 
therefore, our observations were also not due to unwarranted 
extrapolation of the prediction equations.
The comparison of methods for calculation of normal 
values is limited by the fact that different approaches for 
the assessment of hyperinflation have been used. The 
COSYCONET study as well as Koch et al4 used body 
plethysmography, whereas Cordero et al3 used multiple-
breath helium washout. Although these differences limit 
comparability, they do not appear to bias the findings, as has 
been previously discussed.2,4,5 In healthy subjects, ie, those 
used for reference populations, FRC values derived by gas 
washout and body plethysmography are in parallel, whereas 
in COPD larger differences can occur. This, however, does 
not affect the application of the reference values in the 
quantification of deviations from normal, as underlined by 
the consistency of our findings.
Conclusion
Prediction equations for FRC that include body mass appear 
to favor an overestimation of the degree of hyperinflation in 
obese patients with COPD. Therefore, models without body 
weight, like the classical ECSC equations, could be superior 
in the evaluation of FRC in COPD. We believe that research 
groups and clinicians who use body plethysmography as a 
diagnostic tool should be aware of this finding and that the com-
bined effects of COPD-related hyperinflation and BMI on lung 
volume measurements should be studied more thoroughly.
Acknowledgments
This work was supported by the German Federal Ministry 
of Education and Research (BMBF) Competence Network 
Asthma and COPD (ASCONET) and performed in collabo-
ration with the German Center for Lung Research (DZL). 
The project was funded by the BMBF with grant number 
01 GI 0881 and was supported by unrestricted grants from 
AstraZeneca GmbH, Bayer Schering Pharma AG, Boehringer 
Ingelheim Pharma GmbH & Co. KG, Chiesi GmbH, Glaxo-
SmithKline, Grifols Deutschland GmbH, MSD Sharp & 
Dohme GmbH, Mundipharma GmbH, Novartis Deutschland 
GmbH, Pfizer Pharma GmbH, Takeda Pharma Vertrieb 
GmbH & Co. KG and TEVA GmbH for patient investiga-
tions and laboratory measurements. The funding bodies had 
no involvement in the design of the study, or the collection, 
analysis or interpretation of the data.
Disclosure
The authors report no conflicts of interest in this work.
References
1. Criée CP, Sorichter S, Smith HJ, et al. Body plethysmography – its 
principles and clinical use. Respir Med. 2011;105(7):959–971.
2. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, 
Yernault JC. Lung volumes and forced ventilatory flows. Eur Respir J. 
1993;6(Suppl 16):5–40.
3. Cordero PJ, Morales P, Benlloch E, Miravet L, Cebrian J. Static lung 
volumes: reference values from a Latin population of Spanish descent. 
Respiration. 1999;66(3):242–250.
4. Koch B, Friedrich N, Völzke H, et al. Static lung volumes and air-
way resistance reference values in healthy adults. Respirology. 2013; 
18(1):170–178.
5. Garcia-Rio F, Dorgham A, Pino JM, Villasante C, Garcia-Quero C, 
Alvarez-Sala R. Lung volume reference values for women and men 65 to 
85 years of age. Am J Respir Crit Care Med. 2009;180(11):1083–1091.
6. Langer D, Ciavaglia CE, Neder JA, Webb KA, O’Donnell DE. Lung 
hyperinflation in chronic obstructive pulmonary disease: mechanisms, 
clinical implications and treatment. Expert Rev Respir Med. 2014;8(6): 
731–749.
 
In
te
rn
at
io
na
l J
ou
rn
al
 o
f C
hr
on
ic 
O
bs
tru
ct
ive
 P
ul
m
on
ar
y 
Di
se
as
e 
do
wn
lo
ad
ed
 fr
om
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
13
8.
24
6.
2.
19
0 
on
 2
5-
O
ct
-2
01
9
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
International Journal of COPD
Publish your work in this journal
Submit your manuscript here: http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journal
The International Journal of COPD is an international, peer-reviewed 
journal of therapeutics and pharmacology focusing on concise rapid 
reporting of clinical studies and reviews in COPD. Special focus is given 
to the pathophysiological processes underlying the disease, intervention 
programs, patient focused education, and self management protocols. 
This journal is indexed on PubMed Central, MedLine and CAS. The 
manuscript management system is completely online and includes a 
very quick and fair peer-review system, which is all easy to use. Visit 
http://www.dovepress.com/testimonials.php to read real quotes from 
published authors.
International Journal of COPD 2018:13 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
Dovepress
2555
Influence of body mass on FRC %predicted values
 7. Karch A, Vogelmeier C, Welte T, et al. The German COPD cohort 
COSYCONET: aims, methods and descriptive analysis of the study 
population at baseline. Respir Med. 2016;114:27–37.
 8. Wanger J, Clausen JL, Coates A, et al. Standardisation of the measure-
ment of lung volumes. Eur Respir J. 2005;26(3):511–522.
 9. Vogelmeier C, Buhl R, Criée CP, et al. Leitlinie zur Diagnostik 
und Therapie von Patienten mit chronisch obstruktiver Bronchitis 
und Lungenemphysem (COPD) [Guidelines for the diagnosis and 
therapy of COPD issued by Deutsche Atemwegsliga and Deutsche 
Gesellschaft fur Pneumologie und Beatmungsmedizin]. Pneumologie. 
2007;61(5):e1–e40. German.
 10. Quanjer PH, Stanojevic S, Cole TJ, et al; ERS Global Lung Function 
Initiative. Multi-ethnic reference values for spirometry for the 3–95-yr 
age range: the global lung function 2012 equations. Eur Respir J. 2012; 
40(6):1324–1343.
 11. Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the 
diagnosis, management, and prevention of chronic obstructive lung 
disease 2017 report: GOLD executive summary. Eur Respir J. 2017; 
49(3):pii:1700214.
 12. Ladosky W, Botelho MA, Albuquerque JP Jr. Chest mechanics in 
morbidly obese non-hypoventilated patients. Respir Med. 2001;95(4): 
281–286.
 13. Standardized lung function testing. Report working party. Bull Eur 
Physiopathol Respir. 1983;19(Suppl 5):1–95.
 
In
te
rn
at
io
na
l J
ou
rn
al
 o
f C
hr
on
ic 
O
bs
tru
ct
ive
 P
ul
m
on
ar
y 
Di
se
as
e 
do
wn
lo
ad
ed
 fr
om
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
13
8.
24
6.
2.
19
0 
on
 2
5-
O
ct
-2
01
9
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
